Randomized Clinical Trial of Long-Acting Somatostatin for Autosomal Dominant Polycystic Kidney and Liver Disease-Reference-Cited by-同舟云学术

Randomized Clinical Trial of Long-Acting Somatostatin for Autosomal Dominant Polycystic Kidney and Liver Disease

Published:2010-04-29 Issue:6 Volume:21 Page:1052-1061
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Hogan Marie C.,Masyuk Tetyana V.,Page Linda J.,Kubly Vickie J.,Bergstralh Eric J.,Li Xujian,Kim Bohyun,King Bernard F.,Glockner James,Holmes David R.,Rossetti Sandro,Harris Peter C.,LaRusso Nicholas F.,Torres Vicente E.

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference49 articles.

1. Autosomal dominant polycystic kidney disease

2. Identification of a Locus for Autosomal Dominant Polycystic Liver Disease, on Chromosome 19p13.2-13.1

3. Mutations in PRKCSH Cause Isolated Autosomal Dominant Polycystic Liver Disease

4. Mutations in SEC63 cause autosomal dominant polycystic liver disease

5. Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease

Cited by 272 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems;Journal of Alzheimer's Disease;2024-07-16

2. Clinical manifestation, epidemiology, genetic basis, potential molecular targets, and current treatment of polycystic liver disease;Orphanet Journal of Rare Diseases;2024-04-26

3. ACG Clinical Guideline: Focal Liver Lesions;American Journal of Gastroenterology;2024-01-26

4. Predicting autosomal dominant polycystic kidney disease progression: review of promising Serum and urine biomarkers;Frontiers in Pediatrics;2023-11-10

5. Extrarenal Manifestations: Polycystic Liver Disease and Its Complications;Advances in Kidney Disease and Health;2023-09